PwC Report Finds FDA Needs Resources, Communication | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Life sciences companies have mixed opinions on how the US Food and Drug Administration is faring in its efforts to keep up with innovations such as personalized medicine and about the extent communication with the agency is helping to bring new drugs and medical devices to market more swiftly, according to a new industry survey.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.